Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts

201722 citationsJournal Articlehybrid Open Access

Authors

Tessa Niemeyer‐van der Kolk · Centre for Human Drug Research

Marlous R. Dillingh · Centre for Human Drug Research

Rianne Rijneveld · Centre for Human Drug Research

Erica S. Klaassen · Centre for Human Drug Research

Maurits N.C. de Koning · DDL Diagnostic Laboratory

S.T.P. Kouwenhoven · Leiden University Medical Center

Roel E. Genders

Abstract

ICVT was found to be safe for administration to humans and 7 days of active treatment showed a statistical significant wart reduction compared to untreated control lesions, clearly indicating pharmacological activity.

Topics & Keywords

Plant Virus Research Studies Herpesvirus Infections and Treatments Animal Virus Infections Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the European Academy of Dermatology and Venereology

Volume 31, Issue 12, pp. 2088-2090

DOI: 10.1111/jdv.14527

Field-Weighted Citation Impact: 5.07